← Eichor
Study identifier: NCT05287022 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

Condition: Primary Ciliary Dyskinesia  ·  Sponsor: Arkansas Children's Hospital Research Institute

PhaseN/A
Planned participants150
Who can joinAll sexes, 2 Years to 99 Years
Healthy volunteersNo

About this study

this study is aiming at learning more about primary ciliary dyskinesia (PCD) and tests that are used to diagnose this condition. One purpose of this study is to measure the level of nitric oxide in the nasal passages and examine how often the results correlate with other tests currently done to make the diagnosis.

This description comes directly from the study's public registry record.

Talk to the study team

Zena Ghazala, MD  ·  5013641006  ·  zbghazala@uams.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Arkansas Children's HospitalLittle Rock, Arkansas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05287022